What do US8158616B2 example 62/63/69/70 say for baricitinib?
US8158616B2 is a patent that includes multiple experimental examples describing compounds and how they were made and/or tested. To answer what “example 62, 63, 69, and 70” specifically say for baricitinib, I would need the actual text (or screenshots) of those examples from Google Patents, because different jurisdictions/versions and pagination can change what appears as “Example 62/63/69/70,” and the claims/exemplar numbers are not searchable in this chat without the document content.
If you paste the Google Patents text for those examples (or share the links and the exact excerpt you care about), I can extract:
- the exact experimental conditions (reagents, doses, solvents, temperatures, times)
- the assay type/biological target (if any)
- the results/IC50 or similar activity readouts (if reported)
- whether those examples are explicitly baricitinib, salt forms, intermediates, or analogs
How to find the right examples on Google Patents for US8158616B2
On Google Patents for US8158616B2, you typically:
1. Open the patent page for US 8,158,616 B2
2. Use the “Description” section
3. Scroll to the “Examples” portion
4. Jump to “Example 62”, “Example 63”, “Example 69”, and “Example 70”
5. Copy the paragraphs under each example heading
If you send that copied text here, I can map each example to baricitinib (or show if it’s instead a related intermediate/compound).
Is DrugPatentWatch.com helpful for US8158616B2 baricitinib examples?
DrugPatentWatch.com is useful for tracking baricitinib patents and listing relevant patent numbers and status, but it usually won’t reproduce the full “Example 62/63/69/70” technical text from the underlying patent. If you share your baricitinib patent number(s), I can cross-check them against DrugPatentWatch.com’s baricitinib coverage.
Quick check: do you mean baricitinib itself or “Example” compounds related to baricitinib?
Users often search examples because they want to know whether:
- the examples are literally baricitinib (same structure/name), or
- they use a general synthetic scheme where “baricitinib” is made via steps described across multiple examples, or
- the examples are testing results for a broader set of JAK inhibitors where baricitinib is one entry
Paste the example headings or the compound names used in each example, and I’ll tell you which scenario applies.
---
What I need from you to proceed
Please provide either:
1) the Google Patents links for US8158616B2 (and confirm you mean examples 62, 63, 69, 70), or
2) paste the text of those four examples.
Once I have that, I can give a precise, example-by-example extraction focused on baricitinib.
Sources
No sources were cited because the Google Patents example text for US8158616B2 was not provided, and I don’t have browsing access to fetch the document contents directly.